Correlation Between Armada Hflr and Emcure Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Armada Hflr and Emcure Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armada Hflr and Emcure Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Armada Hflr Pr and Emcure Pharmaceuticals, you can compare the effects of market volatilities on Armada Hflr and Emcure Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armada Hflr with a short position of Emcure Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armada Hflr and Emcure Pharmaceuticals.

Diversification Opportunities for Armada Hflr and Emcure Pharmaceuticals

0.25

Correlation Coefficient

Armada Hflr  Emcure Pharmaceuticals

Modest diversification

The 3 months correlation between Armada and Emcure is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Armada Hflr Pr and Emcure Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emcure Pharmaceuticals and Armada Hflr is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armada Hflr Pr are associated (or correlated) with Emcure Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emcure Pharmaceuticals has no effect on the direction of Armada Hflr i.e., Armada Hflr and Emcure Pharmaceuticals go up and down completely randomly.

Pair Corralation between Armada Hflr and Emcure Pharmaceuticals

Considering the 90-day investment horizon Armada Hflr is expected to generate 24.43 times less return on investment than Emcure Pharmaceuticals. But when comparing it to its historical volatility, Armada Hflr Pr is 2.39 times less risky than Emcure Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Emcure Pharmaceuticals is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  100,800  in Emcure Pharmaceuticals on September 23, 2024 and sell it today you would earn a total of  36,490  from holding Emcure Pharmaceuticals or generate 36.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	23.54%
Values	Daily Returns

Armada Hflr Pr  vs.  Emcure Pharmaceuticals

Armada Hflr Pr

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Armada Hflr Pr has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Emcure Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Emcure Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Emcure Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Armada Hflr and Emcure Pharmaceuticals

The main advantage of trading using opposite Armada Hflr and Emcure Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armada Hflr position performs unexpectedly, Emcure Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will offset losses from the drop in Emcure Pharmaceuticals' long position.

The idea behind Armada Hflr Pr and Emcure Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.